Susanne Matthes-Martin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Susanne Matthes-Martin has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
C Peters
3 shared publications- Ulrike Pötschger
Children’s Cancer Research Institute, Vienna, Austria
3 shared publications Andishe Attarbaschi
2 shared publicationsAnita Lawitschka
Department of Paediatrics St. Anna Children's Hospital Medical University Vienna Austria
2 shared publicationsChristina Peters
Department of Paediatrics St. Anna Children's Hospital Medical University Vienna Austria
2 shared publicationsG. Zarbock
Kinderklinik des Universitätskrankenhauses Hamburg-Eppendorf
2 shared publications
Latest Publications
- Open Access
- 4 October 2016
- Published by Springer Nature
- p. 609-621
Adenovirus Infection in Allogeneic Stem Cell Transplantation
- 4 October 2016
- Published by Springer Nature
- p. 609-621
Open AccessAdenovirus Infection in Allogeneic Stem Cell Transplantation
- 1 February 2013
- Published by Wiley in European Journal of Haematology
- Vol. 90 (4) , 308-312
Stem cell transplantation after reduced‐intensity conditioning for sickle cell disease
Sickle cell disease (SCD) is still associated with substantial morbidity and reduced life expectancy. Disease‐related mortality rises to 14% in adolescents and young adults. Overall and disease‐free survival following haematopoietic stem cell transplantation (HSCT) is 90% and 95%, respectively. To reduce transplant‐associated late effects, the feasibility of a highly immunosuppressive reduced‐intensity conditioning (RIC) regimen was explored in children with SCD and a matched sibling donor. Eight patients (median age, 9 yr) and symptomatic SCD were included. The conditioning regimen consisted of fludarabine, melphalan and either thiotepa or total lymphoid irradiation plus antithymocyte globuline or alemtuzumab. The graft was bone marrow in seven and cord blood in one case. The conditioning regimen was well tolerated and no severe infectious complications occurred. All patients displayed mixed chimaerism on day +28. After a median follow‐up of 4 yr, 3/8 patients have mixed leucocyte chimaerism and 8/8 patients have 100% donor erythropoiesis. HSCT from matched sibling donors following a RIC regimen was well tolerated and resulted in cure in all patients studied. If confirmed in larger patient cohorts, these observations will have important implications for the indications of HSCT in children with SCD.
- 1 February 2013
- Published by Wiley in European Journal of Haematology
- Vol. 90 (4) , 308-312
Stem cell transplantation after reduced‐intensity conditioning for sickle cell disease
Sickle cell disease (SCD) is still associated with substantial morbidity and reduced life expectancy. Disease‐related mortality rises to 14% in adolescents and young adults. Overall and disease‐free survival following haematopoietic stem cell transplantation (HSCT) is 90% and 95%, respectively. To reduce transplant‐associated late effects, the feasibility of a highly immunosuppressive reduced‐intensity conditioning (RIC) regimen was explored in children with SCD and a matched sibling donor. Eight patients (median age, 9 yr) and symptomatic SCD were included. The conditioning regimen consisted of fludarabine, melphalan and either thiotepa or total lymphoid irradiation plus antithymocyte globuline or alemtuzumab. The graft was bone marrow in seven and cord blood in one case. The conditioning regimen was well tolerated and no severe infectious complications occurred. All patients displayed mixed chimaerism on day +28. After a median follow‐up of 4 yr, 3/8 patients have mixed leucocyte chimaerism and 8/8 patients have 100% donor erythropoiesis. HSCT from matched sibling donors following a RIC regimen was well tolerated and resulted in cure in all patients studied. If confirmed in larger patient cohorts, these observations will have important implications for the indications of HSCT in children with SCD.
- Open Access
- 1 October 2012
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 18 (10) , 1533-1539
Costs and Cost-Effectiveness of Allogeneic Stem Cell Transplantation in Children Are Predictable
- 1 October 2012
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 18 (10) , 1533-1539
Open AccessCosts and Cost-Effectiveness of Allogeneic Stem Cell Transplantation in Children Are Predictable
- 1 February 2012
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 31 (2) , 115-119
Lethal Pulmonary Complications After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation
Introduction: Hematopoietic stem cell transplantation (HSCT) in children is accompanied by a transplant-related mortality of 10% to 30%, which is the result of lethal pulmonary complications (LPCs) in many cases. Methods: We retrospectively assessed prevalence and risk factors of LPC following 234 allogeneic HSCTs in 228 patients for malignant or nonmalignant diseases at a single institution. Results: Pulmonary complications (PCs) were observed following 81 of 234 transplants (35%). LPCs were observed in 4% of HSCT within 100 days and in 14% within 5 years after HSCT. Late PCs after day 100 were lethal in 56% (22/39) of the patients with PCs, who are 11% (22/202) of all evaluable patients still alive after day +100. Causes of LPC after day 100 were viral (10 cases), bacterial (1 case), fungal (5 cases) pulmonary infection, or noninfectious (6 cases) PCs. Abnormal pretransplant pulmonary function test was not associated with an increased risk of LPC. Children older than 10 years and those undergoing a second HSCT had an increased incidence of overall LPC. T-cell depletion and mismatched donor HSCT (P = 0.001), but not age, were associated with an increased risk of lethal viral pneumonia. Conclusions: Transplant-related mortality up to 5 years after HSCT in children was associated with LPC in 14%. There were more late (>100 days) than early LPCs, predominantly due to infectious etiologies and affecting children >10 years of age.
- 1 February 2012
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 31 (2) , 115-119
Lethal Pulmonary Complications After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation
Introduction: Hematopoietic stem cell transplantation (HSCT) in children is accompanied by a transplant-related mortality of 10% to 30%, which is the result of lethal pulmonary complications (LPCs) in many cases. Methods: We retrospectively assessed prevalence and risk factors of LPC following 234 allogeneic HSCTs in 228 patients for malignant or nonmalignant diseases at a single institution. Results: Pulmonary complications (PCs) were observed following 81 of 234 transplants (35%). LPCs were observed in 4% of HSCT within 100 days and in 14% within 5 years after HSCT. Late PCs after day 100 were lethal in 56% (22/39) of the patients with PCs, who are 11% (22/202) of all evaluable patients still alive after day +100. Causes of LPC after day 100 were viral (10 cases), bacterial (1 case), fungal (5 cases) pulmonary infection, or noninfectious (6 cases) PCs. Abnormal pretransplant pulmonary function test was not associated with an increased risk of LPC. Children older than 10 years and those undergoing a second HSCT had an increased incidence of overall LPC. T-cell depletion and mismatched donor HSCT (P = 0.001), but not age, were associated with an increased risk of lethal viral pneumonia. Conclusions: Transplant-related mortality up to 5 years after HSCT in children was associated with LPC in 14%. There were more late (>100 days) than early LPCs, predominantly due to infectious etiologies and affecting children >10 years of age.
- Open Access
- 1 March 2008
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 14 (3) , 335-343
Risk-Adjusted Outcome Measurement in Pediatric Allogeneic Stem Cell Transplantation
- 1 March 2008
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 14 (3) , 335-343
Open AccessRisk-Adjusted Outcome Measurement in Pediatric Allogeneic Stem Cell Transplantation
- 1 November 2006
- Published by Springer Nature in Monatsschrift Kinderheilkunde
- Vol. 154 (11) , 1098-1103
Allogene Stammzelltransplantation bei Migranten mit nichtmalignen Krankheiten
- 1 November 2006
- Published by Springer Nature in Monatsschrift Kinderheilkunde
- Vol. 154 (11) , 1098-1103
Allogene Stammzelltransplantation bei Migranten mit nichtmalignen Krankheiten
- Open Access
- 17 December 2001
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 28 (11) , 1087-1089
Influence of transplantation regimen on prognostic significance of high-level minimal residual disease before allogeneic stem cell transplantation in children with ALL
- 17 December 2001
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 28 (11) , 1087-1089
Open AccessInfluence of transplantation regimen on prognostic significance of high-level minimal residual disease before allogeneic stem cell transplantation in children with ALL
- 1 December 2000
- Vol. 96 (12) , 3997-9
Successful stem cell transplantation following orthotopic liver transplantation from the same haploidentical family donor in a girl with hemophagocytic lymphohistiocytosis.
The case of a 4-month-old girl with familial hemophagocytic lymphohistiocytosis is described. The patient underwent stem cell transplantation from her haploidentical mother 2 months after receiving a living-related liver transplant from the same donor for acute hepatic failure. Conditioning regimen consisted of 16 mg/kg busulfan, 200 mg/kg cyclophosphamide, 10 mg/kg thiothepa, and antithymocyte globulin. Myeloid engraftment occurred on day +10, but CD3(+) cells of recipient origin remained. To convert the T-cell chimerism, the patient received donor lymphocyte infusion on day +43, and subsequently the allelic pattern changed to complete donor genotype on day +57. Four months after stem cell transplantation the patient is disease free, with complete donor chimerism in bone marrow and stable hepatic graft function without any immunosuppressive therapy. (Blood. 2000;96:3997-3999)
- 1 December 2000
- Vol. 96 (12) , 3997-9
Successful stem cell transplantation following orthotopic liver transplantation from the same haploidentical family donor in a girl with hemophagocytic lymphohistiocytosis.
The case of a 4-month-old girl with familial hemophagocytic lymphohistiocytosis is described. The patient underwent stem cell transplantation from her haploidentical mother 2 months after receiving a living-related liver transplant from the same donor for acute hepatic failure. Conditioning regimen consisted of 16 mg/kg busulfan, 200 mg/kg cyclophosphamide, 10 mg/kg thiothepa, and antithymocyte globulin. Myeloid engraftment occurred on day +10, but CD3(+) cells of recipient origin remained. To convert the T-cell chimerism, the patient received donor lymphocyte infusion on day +43, and subsequently the allelic pattern changed to complete donor genotype on day +57. Four months after stem cell transplantation the patient is disease free, with complete donor chimerism in bone marrow and stable hepatic graft function without any immunosuppressive therapy. (Blood. 2000;96:3997-3999)
- 1 July 1989
- Published by Georg Thieme Verlag KG in Klinische Padiatrie
- Vol. 201 (04) , 337-345
Lebensqualität und Restschadenssymptomatik bei Kleinhirntumoren im Kindes- und Jugendalter*
At the departments of neurosurgery and pediatrics of the University Hospital of Hamburg 21 patients after neurosurgery and radiation of cerebellar tumors have been examined as to neuropsychological, neurological and ophtalmological disabilities. A standardized questionairy for the parents concerning different aspects of their children's quality of life (physical, mental, social health and functional limitations) was performed. 16 children showed minor neurological signs with no or mild disability, in 5 children severe disability was found. In 4 patients morphological changes in the eyeground, in 2 patients amblyopia was detected. 19 patients underwent a neuropsychological examination. The group of patients with medulloblastoma or ependymoma (n = 10) scored in nearly all tests below the group with astrocytoma (n = 9). 3 out of 7 patients in the medulloblastoma or ependymoma group had to abandon school, one patient needs special education. All patients with astrocytoma performed fairly well at school. Parents of patients with medulloblastoma or ependymoma classified their children's quality of life not as good as did parents of children with astrocytoma. The amount of objective disability had no influence on the parents estimation of their children's quality of life. Besides the neurological examination the neuropsychological and quality of life assessment proved to be an essential part of follow up. For a more comprehensive understanding of quality of life, qualitative assessment strategies should be included in further research. 21 Patienten mit Kleinhirntumoren, die in den Jahren 1981-1988 in den Kliniken für Neurochirurgie und Pädiatrie der Universität Hamburg behandelt wurden, konnten auf neuropsychologische, neurologische und ophthalmologische Restschäden nachuntersucht werden. Die Eltern der Patienten wurden mit Hilfe eines standardisierten und normierten Fragebogens zu verschiedenen Dimensionen der Lebensqualität (Allgemeiner Gesundheitszustand, seelische Gesundheit, soziale Beziehungen, funktionelle Beeinträchtigungen) ihrer Kinder befragt. Sechzehn der nachuntersuchten Patienten waren infolge geringer neurologischer Restschadenssymptomatik nicht oder nur leicht behindert, fünf Kinder waren schwer behindert. Bei 4 Patienten bestanden morphologische Veränderungen am Augenhintergrund, 2 dieser Patienten entwickelten nach Erkrankung und Therapie eine Amblyopie. 19 Patienten konnten neuropsychologisch nachuntersucht werden. Die Gruppe der Medulloblastom- und Ependymompatienten (n=10) schnitt in fast allen Funktionsbereichen schlechter ab als die Gruppe der Astrozytompatienten (n = 9). 3 von 7 schulpflichtigen Patienten aus dieser Gruppe mußten den Schulbesuch abbrechen, ein Patient wurde auf eine Sonderschule umgeschult. Die postmorbide schulische Entwicklung der Astrozytompatienten war hingegen unauffällig. Die Ergebnisse der Elternbefragung (s.o.) zeigte, daß die Gruppe der Medulloblastom- und Ependymompatienten in ihrer Lebensqualität tendenziell schlechter eingestuft wurde als die Gruppe der Astrozy-tompatienten. Die von den Eltern beurteilte Lebensqualität ihrer Kinder erwies sich als unabhängig von dem Ausmaß der objektivierbaren Restschadenssymptomatik (Ausnahme: Elternurteil über funktionelle Beeinträchtigung - Ausmaß neurologischer Beeinträchtigung). Auf die Notwendigkeit, in weiteren Untersuchungen den zeitlichen Verlauf der neuropsychologischen und neurologischen Restschadenssymptomatik zu verfolgen, wird hingewiesen. Zur umfassenderen Beurteilung der Lebensqualität wird der zusätzliche Einsatz qualitativer Methoden angeregt.
- 1 July 1989
- Published by Georg Thieme Verlag KG in Klinische Padiatrie
- Vol. 201 (04) , 337-345
Lebensqualität und Restschadenssymptomatik bei Kleinhirntumoren im Kindes- und Jugendalter*
At the departments of neurosurgery and pediatrics of the University Hospital of Hamburg 21 patients after neurosurgery and radiation of cerebellar tumors have been examined as to neuropsychological, neurological and ophtalmological disabilities. A standardized questionairy for the parents concerning different aspects of their children's quality of life (physical, mental, social health and functional limitations) was performed. 16 children showed minor neurological signs with no or mild disability, in 5 children severe disability was found. In 4 patients morphological changes in the eyeground, in 2 patients amblyopia was detected. 19 patients underwent a neuropsychological examination. The group of patients with medulloblastoma or ependymoma (n = 10) scored in nearly all tests below the group with astrocytoma (n = 9). 3 out of 7 patients in the medulloblastoma or ependymoma group had to abandon school, one patient needs special education. All patients with astrocytoma performed fairly well at school. Parents of patients with medulloblastoma or ependymoma classified their children's quality of life not as good as did parents of children with astrocytoma. The amount of objective disability had no influence on the parents estimation of their children's quality of life. Besides the neurological examination the neuropsychological and quality of life assessment proved to be an essential part of follow up. For a more comprehensive understanding of quality of life, qualitative assessment strategies should be included in further research. 21 Patienten mit Kleinhirntumoren, die in den Jahren 1981-1988 in den Kliniken für Neurochirurgie und Pädiatrie der Universität Hamburg behandelt wurden, konnten auf neuropsychologische, neurologische und ophthalmologische Restschäden nachuntersucht werden. Die Eltern der Patienten wurden mit Hilfe eines standardisierten und normierten Fragebogens zu verschiedenen Dimensionen der Lebensqualität (Allgemeiner Gesundheitszustand, seelische Gesundheit, soziale Beziehungen, funktionelle Beeinträchtigungen) ihrer Kinder befragt. Sechzehn der nachuntersuchten Patienten waren infolge geringer neurologischer Restschadenssymptomatik nicht oder nur leicht behindert, fünf Kinder waren schwer behindert. Bei 4 Patienten bestanden morphologische Veränderungen am Augenhintergrund, 2 dieser Patienten entwickelten nach Erkrankung und Therapie eine Amblyopie. 19 Patienten konnten neuropsychologisch nachuntersucht werden. Die Gruppe der Medulloblastom- und Ependymompatienten (n=10) schnitt in fast allen Funktionsbereichen schlechter ab als die Gruppe der Astrozytompatienten (n = 9). 3 von 7 schulpflichtigen Patienten aus dieser Gruppe mußten den Schulbesuch abbrechen, ein Patient wurde auf eine Sonderschule umgeschult. Die postmorbide schulische Entwicklung der Astrozytompatienten war hingegen unauffällig. Die Ergebnisse der Elternbefragung (s.o.) zeigte, daß die Gruppe der Medulloblastom- und Ependymompatienten in ihrer Lebensqualität tendenziell schlechter eingestuft wurde als die Gruppe der Astrozy-tompatienten. Die von den Eltern beurteilte Lebensqualität ihrer Kinder erwies sich als unabhängig von dem Ausmaß der objektivierbaren Restschadenssymptomatik (Ausnahme: Elternurteil über funktionelle Beeinträchtigung - Ausmaß neurologischer Beeinträchtigung). Auf die Notwendigkeit, in weiteren Untersuchungen den zeitlichen Verlauf der neuropsychologischen und neurologischen Restschadenssymptomatik zu verfolgen, wird hingewiesen. Zur umfassenderen Beurteilung der Lebensqualität wird der zusätzliche Einsatz qualitativer Methoden angeregt.